Drugs / adrenocorticotropic hormone
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04306653 | Jan 2018 → Apr 2020 | gout | University of Patras | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adrenocorticotropic hormone | “steroids or adrenocorticotropic hormone (ACTH) may be effective and safe therapeutic options for these patients.” PMID 35445840 ↗ Apr 2022 |
| Known as | ACTH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04306653 ↗ |
| Action | Activate | “ACTH is able to stimulate melanocortin receptors on macrophages and downregulate gouty inflammation.” PMID 24762710 ↗ Oct 2013 |
| Modality | Protein / enzyme biologic | “ACTH, a member of the melanocortin group of proteins” PMID 24762710 ↗ Oct 2013 |